tiprankstipranks
Trending News
More News >
Apimeds Pharmaceuticals US, Inc. (APUS)
:APUS
US Market

Apimeds Pharmaceuticals US, Inc. (APUS) Cash flow

Compare
17 Followers

Apimeds Pharmaceuticals US, Inc. Cash Flow

APUS's free cash flow for Q3 2025 was $-1.75M. For the 2025 fiscal year, APUS's free cash flow was decreased by $-105.74K and operating cash flow was $-1.73M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -733.53K$ -627.79K$ -448.17K$ -823.11K
Investing Cash Flow
$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow
$ 326.50K$ 1.03M$ 282.90K$ 400.00K
End Cash Position
$ 3.46K$ 410.48K$ 6.17K$ 171.44K
Free Cash Flow
$ -733.53K$ -627.79K$ -448.17K$ -823.11K
Currency in USD

Apimeds Pharmaceuticals US, Inc. Cash Flow